Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 15, 2022
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
Wed, September 14, 2022
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
Matthew Harrison Maintained (AKRO) at Hold with Increased Target to $30 on, Sep 14th, 2022
Matthew Harrison of Morgan Stanley, Maintained "Akero Therapeutics, Inc." (AKRO) at Hold with Increased Target from $26 to $30 on, Sep 14th, 2022.
Matthew, nor any peers, have made any analyst calls on AKRO in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30